‘Stu’s Views and MS News’ wants to let you know
about a new co-pay program launched by EMD Serono, Inc. and Pfizer. Although
insurers are paying for an increasing share of prescription drug costs,
patients are still paying more of these overall costs. In fact, doubling
patients’ co-payments for drugs can reduce their use of medications by 25 to 45
percent.
It is with this environment in mind
that EMD Serono, Inc. and Pfizer launched today a $0 co-pay program for Rebif®
(interferon beta-1a) as part of its MS LifeLines Access Made Simple
program. Any eligible person with relapsing multiple sclerosis (MS)
starting Rebif therapy on or after January 22 will have this program available
to them with no additional paperwork. People currently on Rebif therapy can
call MS LifeLines at 1-877-447-3243 to determine eligibility.
that EMD Serono, Inc. and Pfizer launched today a $0 co-pay program for Rebif®
(interferon beta-1a) as part of its MS LifeLines Access Made Simple
program. Any eligible person with relapsing multiple sclerosis (MS)
starting Rebif therapy on or after January 22 will have this program available
to them with no additional paperwork. People currently on Rebif therapy can
call MS LifeLines at 1-877-447-3243 to determine eligibility.
MS LifeLines
Access Made Simple is an access program that provides eligible patients with
co-pay and free drug assistance intended to help patients with the
affordability and access to Rebif.
Access Made Simple is an access program that provides eligible patients with
co-pay and free drug assistance intended to help patients with the
affordability and access to Rebif.
This program
is open to US residents who have a relapsing form of MS and are starting Rebif
therapy or presently taking Rebif therapy. Patients covered by federal and
state healthcare programs are not eligible for assistance. Eligible people
taking Rebif who are currently enrolled in the MS LifeLines Access Made Simple
program will be automatically enrolled in the $0 co-pay program by April 1,
2014.
is open to US residents who have a relapsing form of MS and are starting Rebif
therapy or presently taking Rebif therapy. Patients covered by federal and
state healthcare programs are not eligible for assistance. Eligible people
taking Rebif who are currently enrolled in the MS LifeLines Access Made Simple
program will be automatically enrolled in the $0 co-pay program by April 1,
2014.
EMD Serono
and Pfizer are committed to helping people living with relapsing MS start and
stay on Rebif as prescribed. The introduction of the $0 co-pay program
signifies the companies’ commitment to the MS community and dedication to
providing even more affordable access to therapy.
and Pfizer are committed to helping people living with relapsing MS start and
stay on Rebif as prescribed. The introduction of the $0 co-pay program
signifies the companies’ commitment to the MS community and dedication to
providing even more affordable access to therapy.
For more information about the MS LifeLines
Access Made Simple $0 co-pay program, call 1-877-447-3243 to speak with a
Reimbursement Case Specialist. You can also visit MSLifeLines.com to learn
more.
Access Made Simple $0 co-pay program, call 1-877-447-3243 to speak with a
Reimbursement Case Specialist. You can also visit MSLifeLines.com to learn
more.
About MS
LifeLines
LifeLines
At the heart
of the MS LifeLines network is its call center, which marked a milestone in 2010
by answering one million in-bound calls from the MS community. The call center
includes patient enrollment specialists, patient support specialists, nurse
support specialists and reimbursement specialists. Whenever someone in the MS
community needs to speak with a live person, support is available toll-free at
1-877-447-3243. The MS community can also visit MS LifeLines online at www.mslifelines.com.
of the MS LifeLines network is its call center, which marked a milestone in 2010
by answering one million in-bound calls from the MS community. The call center
includes patient enrollment specialists, patient support specialists, nurse
support specialists and reimbursement specialists. Whenever someone in the MS
community needs to speak with a live person, support is available toll-free at
1-877-447-3243. The MS community can also visit MS LifeLines online at www.mslifelines.com.
About
Rebif® (interferon beta-1a)
Rebif® (interferon beta-1a)
Rebif is used
to treat relapsing forms of MS to decrease the frequency of relapses and delay
the occurrence of some of the physical disability that is common in people with
MS. Rebif is not approved for treatment of chronic progressive MS. Rebif is
available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration
pack.
to treat relapsing forms of MS to decrease the frequency of relapses and delay
the occurrence of some of the physical disability that is common in people with
MS. Rebif is not approved for treatment of chronic progressive MS. Rebif is
available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration
pack.
Rebif will
not cure MS but it has been shown to decrease the number of flare-ups and slow
the occurrence of some of the physical disability that is common in people with
MS. Rebif can cause serious side effects, so before taking Rebif,
patients should talk with their doctor about the possible benefits of Rebif and
its possible side effects.
not cure MS but it has been shown to decrease the number of flare-ups and slow
the occurrence of some of the physical disability that is common in people with
MS. Rebif can cause serious side effects, so before taking Rebif,
patients should talk with their doctor about the possible benefits of Rebif and
its possible side effects.
Potential
serious side effects of Rebif include depression, liver problems, risk to
pregnancy, allergic reactions and injection-site problems. Patients who have
had an allergic reaction such as difficulty breathing, flushing or hives to
another interferon beta or to human albumin should not take Rebif.
serious side effects of Rebif include depression, liver problems, risk to
pregnancy, allergic reactions and injection-site problems. Patients who have
had an allergic reaction such as difficulty breathing, flushing or hives to
another interferon beta or to human albumin should not take Rebif.
Before taking
Rebif, patients should tell their doctor if they have a history of depression,
anxiety, trouble sleeping, liver disease, thyroid problems, blood cell count or
bleeding problems, epilepsy, or are planning to become pregnant. Patients
should tell their doctor about all medicines they take, including prescription
and non-prescription medicines, vitamins and herbal supplements. Rebif and
other medicines may affect each other causing serious side effects. Patients
should talk to their doctor before taking any new medicines.
Rebif, patients should tell their doctor if they have a history of depression,
anxiety, trouble sleeping, liver disease, thyroid problems, blood cell count or
bleeding problems, epilepsy, or are planning to become pregnant. Patients
should tell their doctor about all medicines they take, including prescription
and non-prescription medicines, vitamins and herbal supplements. Rebif and
other medicines may affect each other causing serious side effects. Patients
should talk to their doctor before taking any new medicines.
Possible side
effects of Rebif include flu-like symptoms (fever, chills, sweating, muscle
aches and tiredness), injection-site reactions, depression and anxiety, liver
problems, abdominal pain, blood problems, thyroid problems and severe allergic
reactions. Patients should let their doctor know if they have any of these
symptoms or feel sad, tired, hot or cold, or experience hives, rashes,
bruising, yellowing of the skin, or a change in body weight (gain or loss).
effects of Rebif include flu-like symptoms (fever, chills, sweating, muscle
aches and tiredness), injection-site reactions, depression and anxiety, liver
problems, abdominal pain, blood problems, thyroid problems and severe allergic
reactions. Patients should let their doctor know if they have any of these
symptoms or feel sad, tired, hot or cold, or experience hives, rashes,
bruising, yellowing of the skin, or a change in body weight (gain or loss).
This
information is not intended to replace discussions with a doctor. For additional
information about Rebif, please consult the Prescribing Information and Medication Guide at www.rebif.com and talk to a doctor. Information is
also available at www.mslifelines.com or call toll-free 1-877-44-REBIF
(1-877-447-3243). Rebif is available by prescription only.
information is not intended to replace discussions with a doctor. For additional
information about Rebif, please consult the Prescribing Information and Medication Guide at www.rebif.com and talk to a doctor. Information is
also available at www.mslifelines.com or call toll-free 1-877-44-REBIF
(1-877-447-3243). Rebif is available by prescription only.
If you would like, you can comment to our blog posts
LIKE this Blog by clicking the LIKE button – top left
REMAIN up to date with MS News and Education
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
